Paul F Smith Selected Research

Neoplasms (Cancer)

1/2019	A multivariate statistical analysis of the effects of styrene maleic acid encapsulated RL71 in a xenograft model of triple negative breast cancer.
9/2013	Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.
11/2009	Cannabinoids in the treatment of cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul F Smith Research Topics

Disease

22	Tinnitus 01/2021 - 07/2005
9	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2021 - 03/2010
7	Multiple Sclerosis 03/2010 - 06/2002
6	Bilateral Vestibulopathy 01/2018 - 01/2008
4	Pain (Aches) 07/2004 - 06/2002
3	Cognitive Dysfunction 01/2020 - 12/2011
3	Neoplasms (Cancer) 01/2019 - 11/2009
3	Chronic Pain 01/2019 - 06/2002
3	Ischemia 12/2003 - 06/2002
2	Epilepsy (Aura) 01/2019 - 07/2005
2	Neuralgia (Stump Neuralgia) 01/2019 - 07/2003
2	Dementia (Dementias) 01/2017 - 06/2002
2	Alzheimer Disease (Alzheimer's Disease) 12/2011 - 07/2003
2	Dizziness (Lightheadedness) 09/2010 - 01/2006
2	Vertigo (Positional Vertigo) 09/2010 - 01/2006
2	Psychotic Disorders (Schizoaffective Disorder) 03/2010 - 05/2005
2	Hypoxia (Hypoxemia) 12/2003 - 06/2002
1	Parkinson Disease (Parkinson's Disease) 02/2022
1	Mental Disorders (Mental Disorder) 01/2021
1	Hyperacusis (Phonophobia) 01/2021
1	Sensorineural Hearing Loss 01/2021
1	Triple Negative Breast Neoplasms 01/2019
1	Atrophy 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 08/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2013
1	Melanoma (Melanoma, Malignant) 09/2013
1	Skin Neoplasms (Skin Cancer) 09/2013
1	Memory Disorders (Memory Loss) 01/2013
1	Movement Disorders (Movement Disorder) 02/2012
1	Breast Neoplasms (Breast Cancer) 11/2009
1	Tremor (Tremors) 05/2008
1	Ataxia (Dyssynergia) 05/2008
1	Shock 01/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2007
1	Meniere Disease (Menieres Disease) 07/2005
1	Sensory Partial Epilepsy 07/2005

Drug/Important Bio-Agent (IBA)

15	CannabinoidsIBA 01/2019 - 06/2002
11	Pharmaceutical PreparationsIBA 01/2021 - 07/2004
6	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2012
5	SalicylatesIBA 09/2010 - 12/2006
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 07/2003
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2016 - 07/2005
3	Cannabinoid Receptor AgonistsIBA 02/2016 - 11/2009
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2008
2	PlacebosIBA 01/2015 - 01/2015
2	CannabidiolIBA 01/2015 - 07/2004
2	Baclofen FDA LinkGeneric 02/2012 - 01/2012
2	N-Methylaspartate (NMDA)IBA 01/2012 - 07/2003
2	Memantine (Namenda)FDA Link 01/2012 - 07/2003
2	Antidepressive Agents (Antidepressants)IBA 09/2010 - 01/2007
2	Dronabinol (THC)FDA LinkGeneric 01/2008 - 07/2004
2	BenzodiazepinesIBA 01/2007 - 07/2005
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2007 - 07/2005
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2006 - 07/2005
1	Opioid Analgesics (Opioids)IBA 01/2021
1	maleic acid (maleate)IBA 01/2019
1	Styrene (Styrol)IBA 01/2019
1	Capsules (Microcapsules)IBA 01/2017
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2016
1	Melanocortin Receptors (Melanocortin Receptor)IBA 08/2015
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 08/2015
1	Type 3 Melanocortin ReceptorIBA 08/2015
1	butir-His-Phe-Arg-Trp-Sar-NH2IBA 08/2015
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2015
1	OrexinsIBA 01/2014
1	VanadiumIBA 09/2013
1	MetalsIBA 09/2013
1	cobalt tetrasulfophthalocyanineIBA 09/2013
1	RutheniumIBA 09/2013
1	SaltsIBA 09/2013
1	SodiumIBA 09/2013
1	ChloridesIBA 09/2013
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 11/2012
1	Dopamine Receptors (Dopamine Receptor)IBA 02/2012
1	Nootropic Agents (Nootropics)IBA 12/2011
1	AMPA Receptors (AMPA Receptor)IBA 12/2011
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 09/2010
1	Serotonin (5 Hydroxytryptamine)IBA 09/2010
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2010
1	EMF01IBA 03/2010
1	Estrogen ReceptorsIBA 11/2009
1	EnzymesIBA 05/2008
1	Dopamine (Intropin)FDA LinkGeneric 05/2008
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2008
1	Protein Isoforms (Isoforms)IBA 12/2006
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2006
1	Gentamicins (Gentamicin)FDA LinkGeneric 07/2005
1	Lidocaine (Xylocaine)FDA LinkGeneric 07/2005
1	SteroidsIBA 07/2005

Therapy/Procedure

2	Therapeutics 01/2021 - 08/2005
2	Injections 06/2007 - 12/2006
1	Deep Brain Stimulation 02/2022
1	Electrodes (Electrode) 02/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2010